Recovery Watch headlines:

  • Pfizer/BioNTech vaccine appears highly effective against South African variant
  • Oxford/AstraZeneca rollout halted for some in Europe, as regulators conclude that unusual blood clots should be listed as a ‘possible but very rare’ side effect
  • Policymakers make very cautious assumptions about the pace of recovery…

[Please click below to read the full note.]